Drug Shortage Report for VYVANSE

Last updated on 2017-04-13 History
Report ID 5797
Drug Identification Number 02439603
Brand name VYVANSE
Common or Proper name Lisdexamfetamine
Company Name SHIRE PHARMA CANADA ULC
Active Ingredient(s) LISDEXAMFETAMINE DIMESYLATE
Strength(s) 10MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size Bottles of 100 capsules
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-04-04
Actual start date 2017-04-04
Estimated end date 2017-04-11
Actual end date 2017-04-12
Shortage status Resolved
Updated date 2017-04-13
Company comments Shire Distribution Center shortage only. Patient impact is not anticipated.
Health Canada comments
Contact Address 22 ADELAIDE ST WEST, SUITE 3800
TORONTO, ONTARIO
CANADA M5H 4E3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2017-04-13 English Compare
v12 2017-04-12 French Compare
v11 2017-04-12 English Compare
v10 2017-04-06 French Compare
v9 2017-04-06 English Compare
v8 2017-04-06 French Compare
v7 2017-04-06 English Compare
v6 2017-04-06 French Compare
v5 2017-04-06 English Compare
v4 2017-04-06 French Compare
v3 2017-04-06 English Compare
v2 2017-04-06 French Compare
v1 2017-04-06 English Compare